Norovirus gastroenteritis successfully treated with nitazoxanide
- PMID: 21839773
- PMCID: PMC3368802
- DOI: 10.1016/j.jinf.2011.08.002
Norovirus gastroenteritis successfully treated with nitazoxanide
Abstract
Infectious diarrhea is a common occurrence in the immunosuppressed population. We present a 43-year-old individual with large-volume stool output Norovirus acute gastroenteritis in the setting of relapsed refractory acute myelogenous leukemia, hematopoietic stem cell transplantation, and biopsy-proven cutaneous and pulmonary graft-versus-host disease. Therapeutic options such as intravenous immunoglobulin or reduction of immunosuppressants were not a feasible choice. A prompt clinical cure was achieved with nitazoxanide, a broad-spectrum antimicrobial agent. Nitazoxanide may be a safe therapeutic alternative, in which a reduction in immunosuppression may not be a viable option.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
References
-
- Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology. 2006;346(2):312–323. - PubMed
-
- Teunis PF, Moe CL, Liu P, et al. Norwalk virus: how infectious is it? J Med Virol. 2008;80(8):1468–1476. - PubMed
-
- Centers for Disease Control and Prevention (CDC) Norovirus activity-United States, 2006–2007. MMWR Morb Mortal Wkly Rep. 2007;56(33):842–846. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
